Literature DB >> 21615216

The Nell-1 growth factor stimulates bone formation by purified human perivascular cells.

Xinli Zhang1, Bruno Péault, Weiwei Chen, Weiming Li, Mirko Corselli, Aaron W James, Min Lee, Ronald K Siu, Pang Shen, Zhong Zheng, Jia Shen, Jinny Kwak, Janette N Zara, Feng Chen, Hong Zhang, Zack Yin, Ben Wu, Kang Ting, Chia Soo.   

Abstract

The search for novel sources of stem cells other than bone marrow mesenchymal stem cells (MSCs) for bone regeneration and repair has been a critical endeavor. We previously established an effective protocol to homogeneously purify human pericytes from multiple fetal and adult tissues, including adipose, bone marrow, skeletal muscle, and pancreas, and identified pericytes as a primitive origin of human MSCs. In the present study, we further characterized the osteogenic potential of purified human pericytes combined with a novel osteoinductive growth factor, Nell-1. Purified pericytes grown on either standard culture ware or human cancellous bone chip (hCBC) scaffolds exhibited robust osteogenic differentiation in vitro. Using a nude mouse muscle pouch model, pericytes formed significant new bone in vivo as compared to scaffold alone (hCBC). Moreover, Nell-1 significantly increased pericyte osteogenic differentiation, both in vitro and in vivo. Interestingly, Nell-1 significantly induced pericyte proliferation and was observed to have pro-angiogenic effects, both in vitro and in vivo. These studies suggest that pericytes are a potential new cell source for future efforts in skeletal regenerative medicine, and that Nell-1 is a candidate growth factor able to induce pericyte osteogenic differentiation. © Mary Ann Liebert, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21615216      PMCID: PMC3179623          DOI: 10.1089/ten.TEA.2010.0705

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   3.845


  48 in total

1.  In vivo bone regeneration with injectable calcium phosphate biomaterial: a three-dimensional micro-computed tomographic, biomechanical and SEM study.

Authors:  Olivier Gauthier; Ralph Müller; Dietrich von Stechow; Bernard Lamy; Pierre Weiss; Jean-Michel Bouler; Eric Aguado; Guy Daculsi
Journal:  Biomaterials       Date:  2005-09       Impact factor: 12.479

2.  Prospective identification of myogenic endothelial cells in human skeletal muscle.

Authors:  Bo Zheng; Baohong Cao; Mihaela Crisan; Bin Sun; Guangheng Li; Alison Logar; Solomon Yap; Jonathan B Pollett; Lauren Drowley; Theresa Cassino; Burhan Gharaibeh; Bridget M Deasy; Johnny Huard; Bruno Péault
Journal:  Nat Biotechnol       Date:  2007-09-02       Impact factor: 54.908

Review 3.  New era of cell-based orthopedic therapies.

Authors:  Arnold I Caplan
Journal:  Tissue Eng Part B Rev       Date:  2009-06       Impact factor: 6.389

4.  Induction of angiogenesis in tissue-engineered scaffolds designed for bone repair: a combined gene therapy-cell transplantation approach.

Authors:  Ehsan Jabbarzadeh; Trevor Starnes; Yusuf M Khan; Tao Jiang; Anthony J Wirtel; Meng Deng; Qing Lv; Lakshmi S Nair; Steven B Doty; Cato T Laurencin
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-04       Impact factor: 11.205

5.  A perivascular origin for mesenchymal stem cells in multiple human organs.

Authors:  Mihaela Crisan; Solomon Yap; Louis Casteilla; Chien-Wen Chen; Mirko Corselli; Tea Soon Park; Gabriella Andriolo; Bin Sun; Bo Zheng; Li Zhang; Cyrille Norotte; Pang-Ning Teng; Jeremy Traas; Rebecca Schugar; Bridget M Deasy; Stephen Badylak; Hans-Jörg Buhring; Jean-Paul Giacobino; Lorenza Lazzari; Johnny Huard; Bruno Péault
Journal:  Cell Stem Cell       Date:  2008-09-11       Impact factor: 24.633

6.  Perivascular niche of postnatal mesenchymal stem cells in human bone marrow and dental pulp.

Authors:  Songtao Shi; Stan Gronthos
Journal:  J Bone Miner Res       Date:  2003-04       Impact factor: 6.741

7.  Craniosynostosis-associated gene nell-1 is regulated by runx2.

Authors:  Thien Truong; Xinli Zhang; Dharmini Pathmanathan; Chia Soo; Kang Ting
Journal:  J Bone Miner Res       Date:  2007-01       Impact factor: 6.741

8.  Nell-1 induced bone formation within the distracted intermaxillary suture.

Authors:  Catherine M Cowan; Samson Cheng; Kang Ting; Chia Soo; Benjamin Walder; Benjamin Wu; Shun'ichi Kuroda; Xinli Zhang
Journal:  Bone       Date:  2005-10-20       Impact factor: 4.398

Review 9.  Repairing skeletal muscle: regenerative potential of skeletal muscle stem cells.

Authors:  Francesco Saverio Tedesco; Arianna Dellavalle; Jordi Diaz-Manera; Graziella Messina; Giulio Cossu
Journal:  J Clin Invest       Date:  2010-01       Impact factor: 14.808

10.  Overexpression of Nell-1, a craniosynostosis-associated gene, induces apoptosis in osteoblasts during craniofacial development.

Authors:  Xinli Zhang; Dale Carpenter; Nobuyuki Bokui; Chia Soo; Steve Miao; Thien Truong; Benjamin Wu; Ingrid Chen; Heleni Vastardis; Katsuyuki Tanizawa; Shun'ichi Kuroda; Kang Ting
Journal:  J Bone Miner Res       Date:  2003-12       Impact factor: 6.741

View more
  31 in total

1.  Osteogenic differentiation of human amniotic epithelial cells and its application in alveolar defect restoration.

Authors:  Si Jiawen; Zhang Jianjun; Dai Jiewen; Yu Dedong; Yu Hongbo; Shi Jun; Wang Xudong; Steve G F Shen; Guo Lihe
Journal:  Stem Cells Transl Med       Date:  2014-11-03       Impact factor: 6.940

2.  Nell-1 Is a Key Functional Modulator in Osteochondrogenesis and Beyond.

Authors:  C Li; X Zhang; Z Zheng; A Nguyen; K Ting; C Soo
Journal:  J Dent Res       Date:  2019-10-14       Impact factor: 6.116

3.  Calvarial Defect Healing Induced by Small Molecule Smoothened Agonist.

Authors:  Soonchul Lee; Jia Shen; Hsin Chuan Pan; Swati Shrestha; Greg Asatrian; Alan Nguyen; Carolyn Meyers; Vi Nguyen; Min Lee; Chia Soo; Kang Ting; Aaron W James
Journal:  Tissue Eng Part A       Date:  2016-10-18       Impact factor: 3.845

4.  NELL-1 promotes cartilage regeneration in an in vivo rabbit model.

Authors:  Ronald K Siu; Janette N Zara; Yaping Hou; Aaron W James; Jinny Kwak; Xinli Zhang; Kang Ting; Benjamin M Wu; Chia Soo; Min Lee
Journal:  Tissue Eng Part A       Date:  2011-10-11       Impact factor: 3.845

Review 5.  Understanding angiogenesis and the role of angiogenic growth factors in the vascularisation of engineered tissues.

Authors:  Nicolas Pavlos Omorphos; Chuanyu Gao; Miljyot Singh Sangha; Sian See Tan
Journal:  Mol Biol Rep       Date:  2021-01-03       Impact factor: 2.316

6.  Lineage-Specific Wnt Reporter Elucidates Mesenchymal Wnt Signaling during Bone Repair.

Authors:  Leslie Chang; Lei Zhang; Jiajia Xu; Carolyn A Meyers; Zhu Li; Noah Yan; Erin Zou; Aaron W James
Journal:  Am J Pathol       Date:  2018-07-20       Impact factor: 4.307

7.  Fibromodulin reprogrammed cells: A novel cell source for bone regeneration.

Authors:  Chen-Shuang Li; Pu Yang; Kang Ting; Tara Aghaloo; Soonchul Lee; Yulong Zhang; Kambiz Khalilinejad; Maxwell C Murphy; Hsin Chuan Pan; Xinli Zhang; Benjamin Wu; Yan-Heng Zhou; Zhihe Zhao; Zhong Zheng; Chia Soo
Journal:  Biomaterials       Date:  2016-01-07       Impact factor: 12.479

8.  Human perivascular stem cells show enhanced osteogenesis and vasculogenesis with Nel-like molecule I protein.

Authors:  Asal Askarinam; Aaron W James; Janette N Zara; Raghav Goyal; Mirko Corselli; Angel Pan; Pei Liang; Le Chang; Todd Rackohn; David Stoker; Xinli Zhang; Kang Ting; Bruno Péault; Chia Soo
Journal:  Tissue Eng Part A       Date:  2013-04-04       Impact factor: 3.845

9.  Accelerated Chondrogenic Differentiation of Human Perivascular Stem Cells with NELL-1.

Authors:  Chen-Shuang Li; Xinli Zhang; Bruno Péault; Jie Jiang; Kang Ting; Chia Soo; Yan-Heng Zhou
Journal:  Tissue Eng Part A       Date:  2016-01-27       Impact factor: 3.845

10.  BMP2-induced inflammation can be suppressed by the osteoinductive growth factor NELL-1.

Authors:  Jia Shen; Aaron W James; Janette N Zara; Greg Asatrian; Kevork Khadarian; James B Zhang; Stephanie Ho; Hyun Ju Kim; Kang Ting; Chia Soo
Journal:  Tissue Eng Part A       Date:  2013-07-17       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.